Molecular conjugate

US9310373B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9310373-B2
Application numberUS-201414181391-A
CountryUS
Kind codeB2
Filing dateFeb 14, 2014
Priority dateNov 23, 2005
Publication dateApr 12, 2016
Grant dateApr 12, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method is disclosed for making a conjugate of two molecules using a hydrazide thiol linker. In a particular working embodiment, an Fc-specific antibody-enzyme conjugate is made using the method and demonstrated to provide exceptional staining sensitivity and specificity in immunohistochemical and in situ hybridization assays.

First claim

Opening claim text (preview).

We claim: 1. A kit, comprising: a conjugate, comprising an antibody, a detectable label comprising an enzyme including about 17-25 maleimide groups introduced into the enzyme by NHS-PEG-maleimide linkers, each linker being covalently bonded to an amino group of the enzyme, and a plurality of hydrazide thiol linkers, each hydrazide thiol linker comprising one or more linking atoms positioned between a hydrazide group and a thiol group, wherein the hydrazide thiol linker is selected from mercaptobutyric acid hydrazide (MBH), mercaptobutyric acid carbohydrazide (MBCH), mercaptoacetamido-mercaptobutyric acid hydrazide (MAMBH), thiohexanamidomercaptobutyric acid hydrazide (THMBH), N,N′-(6-hydrazinyl-6-oxohexane-1,5-diyl)bis(2-mercaptoacetamide) (BTAL), bisthiohexanamidohydrazidolysine (BTHL), N-(1,5-dihydrazinyl-1,5-dioxopentan-2-yl)2-mercaptoacetamide (TAGD), thiohexamidoglutamic acid dihydrazide (THGD), a PEG-based hydrazide-thiol linker, a multifunctional hydrazide thiol linker, a PEG-based multifunctional hydrazide thiol linker, a polyacrylamide hydrazide thiol linker, and combinations thereof, the hydrazide group of each hydrazide thiol linker being covalently bonded to an oxidized glycosylated Fc portion of the antibody and the thiol group of one of the hydrazide thiol linkers being covalently bonded to the detectable label via one of the maleimide groups. 2. The kit of claim 1 , wherein the hydrazide thiol linker comprises a PEG-based hydrazide thiol linker. 3. The kit of claim 2 , wherein the PEG-based hydrazide thiol linker comprises a mercapto-dPEG-hydrazide linker. 4. The kit of claim 1 , wherein the hydrazide thiol linker comprises MBH or MBCH. 5. The kit of claim 1 , wherein the enzyme is alkaline phosphatase or horseradish peroxidase. 6. The kit of claim 5 , wherein the enzyme is alkaline phosphatase. 7. The kit of claim 6 , wherein the alkaline phosphatase comprises cross-linked alkaline phosphatase. 8. The kit of claim 1 , wherein the antibody comprises an anti-hapten antibody. 9. The kit of claim 1 , wherein the antibody comprises an anti-antibody antibody. 10. A method for detecting a molecule of interest in a cell or tissue sample, comprising: contacting the cell or the tissue sample with a primary antibody specifically recognizing the molecule of interest in the cell or the tissue sample to provide the cell or the tissue sample bound with the primary antibody contacting the cell or tissue sample with a conjugate comprising an antibody capable of specifically recognizing the primary antibody, a detectable label comprising an enzyme including about 17-25 maleimide groups introduced into the enzyme by NHS-PEG-maleimide linkers, each linker being covalently bonded to an amino group of the enzyme, and a plurality of hydrazide thiol linkers, each hydrazide thiol linker comprising one or more linking atoms positioned between a hydrazide group and a thiol group, wherein the hydrazide thiol linker is selected from mercaptobutyric acid hydrazide (MBH), mercaptobutyric acid carbohydrazide (MBCH), mercaptoacetamido-mercaptobutyric acid hydrazide (MAMBH), thiohexanamidomercaptobutyric acid hydrazide (THMBH), N,N′-(6-hydrazinyl-6-oxohexane-1,5-diyl)bis(2-mercaptoacetamide) (BTAL), bisthiohexanamidohydrazidolysine (BTHL), N-(1,5-dihydrazinyl-1,5-dioxopentan-2-yl)2-mercaptoacetamide (TAGD), thiohexamidoglutamic acid dihydrazide (THGD), a PEG-based hydrazide-thiol linker, a multifunctional hydrazide thiol linker, a PEG-based multifunctional hydrazide thiol linker, a polyacrylamide hydrazide thiol linker, and combinations thereof, the hydrazide group of each hydrazide thiol linker being covalently bonded to an oxidized glycosylated Fc portion of the antibody and the thiol group of one of the hydrazide thiol linkers being covalently bonded to one of the maleimide groups on the enzyme; and detecting a signal generated by the conjugate that are bound to the primary antibody indicating the presence of the molecule of interest in the cell or tissue sample. 11. The method of claim 10 , wherein the hydrazide thiol linker comprises a PEG-based hydrazide thiol linker. 12. The method of claim 11 , wherein the PEG-based hydrazide thiol linker comprises a mercapto-dPEG-hydrazide linker. 13. The method of claim 10 , wherein the hydrazide thiol linker comprises MBH or MBCH. 14. The method of claim 10 , wherein the enzyme is alkaline phosphatase or horseradish peroxidase. 15. The method of claim 14 , wherein the enzyme is alkaline phosphatase. 16. The method of claim 15 , wherein the alkaline phosphatase comprises cross-linked alkaline phosphatase.

Assignees

Inventors

Classifications

  • having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms · CPC title

  • with enzyme label {or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates} · CPC title

  • Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies · CPC title

  • Production of labelled immunochemicals · CPC title

  • Antibodies bound to carriers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9310373B2 cover?
A method is disclosed for making a conjugate of two molecules using a hydrazide thiol linker. In a particular working embodiment, an Fc-specific antibody-enzyme conjugate is made using the method and demonstrated to provide exceptional staining sensitivity and specificity in immunohistochemical and in situ hybridization assays.
Who is the assignee on this patent?
Ventana Med Syst Inc
What technology area does this patent fall under?
Primary CPC classification G01N33/53. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).